Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status

Louis P. Garrison, Deepa Lalla, Melissa Brammer, Joseph B. Babigumira, Bruce Wang, Edith A. Perez

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status'. Together they form a unique fingerprint.

Medicine & Life Sciences